Welcome to The Aurum Institute - A Leading African Health Impact Organisation

English English

Latest News & Updates

Here, you'll discover all the latest news & updates from The Aurum Institute

Latest News

A proposal for an international research project involving the Aurum Institute has been shortlisted for a $100 million grant.

The proposal by the Vanderbilt University Medical Center (VUMC) was one of the highest scoring, placing it in the Top 100 for the John D and Catherine T MacArthur Foundation’s 100&Change grant. The proposal is for the Remedi project, which aims to improve global health by Repurposing Essential Medicines Internationally (Remedi).

No safety concerns found; NIH and partners discontinue vaccinations.

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has stopped administration of vaccinations in its HVTN 702 clinical trial of an investigational HIV vaccine. This action was taken because an independent data and safety monitoring board (DSMB) found during an interim review that the regimen did not prevent HIV. Importantly, the DSMB did not express any concern regarding participant safety.

This article was published in Daily Maverick on 28 January 2020.


Geoff Setswe, a public health expert with global health impact organisation, The Aurum Institute, tells us that the NHI is no different to any other structural change implemented in the health system. However, implementing it in South Africa will be a challenge.


The next three and a half years, KNCV Tuberculosis Foundation will lead the innovative ASCENT project, which stands for Adherence Support Coalition to End TB. This brand new project is funded by Unitaid through a grant of almost US$ 14 million and will be implemented in five different countries (Ethiopia, Tanzania, the Philippines, South Africa and Ukraine). It will support TB patients during their treatment with digital adherence technologies. These groundbreaking innovations have great added value for both patients and caregivers.

The 10th IAS Conference on HIV Science – known as IAS 2019 – will take place on 21-24 July 2019 in Mexico City, Mexico. The IAS Conference on HIV Science is the world’s most influential meeting on HIV research and its applications. This biennial conference presents the critical advances in basic, clinical and operational research that moves science into policy and practice. Through its open and inclusive programme development, the meeting sets the gold standard of HIV research featuring highly diverse and cutting-edge studies.

JOHANNESBERG, SOUTH AFRICA - An innovative system to dispense medicine to patients with chronic illnesses is taking off in South Africa. The award-winning “Pelebox,” created by South African engineer Neo Hutiri, is a computer-controlled vending machine stocked with prescription drugs, which patients
access using a personal code.

Page 1 of 4